| General information | Literature | Expression | Regulation | Mutation | Homolog | Interaction |
Basic Information | |
|---|---|
Gene ID | 596 |
Name | BCL2 |
Synonymous | B-cell CLL/lymphoma 2;BCL2;B-cell CLL/lymphoma 2 |
Definition | apoptosis regulator Bcl-2|protein phosphatase 1, regulatory subunit 50 |
Position | 18q21.3 |
Gene Type | protein-coding |
Gene Regulation: | Transcription Factors Post Transcriptional Modification From dbPTM Methylation Profile From DiseaseMeth database |
Transcription Factors [Top] |
Regulation From TransFac database | 2 Bcl-2(h) <==> Bcl-2(h):Bcl-2(h) (binding) | Bcl-2(h) + Bax(h) <==> Bcl-2(h):Bax(h) (binding) | Bcl-2(h) + Bax(m) <==> Bcl-2(h):Bax(m) (binding) | BimS(m) + Bcl-2(h) <==> BimS(m):Bcl-2(h) (binding) | BimL(m) + Bcl-2(h) <==> BimL(m):Bcl-2(h) (binding) | BimEL(m) + Bcl-2(h) <==> BimEL(m):Bcl-2(h) (binding) | Hrk(h) + Bcl-2(h) <==> Hrk(h):Bcl-2(h) (binding) | DEBCL(d) + Bcl-2(h) <==> DEBCL(d):Bcl-2(h) (binding) | Bcl-2(h) + BimL(m) + LC8(m) <==> Bcl-2(h):BimL(m):LC8(m) (binding) | BAR(h) + Bcl-2(h) <==> BAR(h):Bcl-2(h) (binding) | Bcl-B(h) + Bcl-2(h) <==> Bcl-B(h):Bcl-2(h) (binding) | Bik(m) + Bcl-2(h) <==> Bik(m):Bcl-2(h) (binding) | bag1(m) + Bcl-2(h) <==> bag1(m):Bcl-2(h) (binding) | bag1(m) + Bcl-2(h) + Raf-1(h) <==> bag1(m):Bcl-2(h):Raf-1(h) (binding) | Bcl-2(h) + PS1(h) <==> Bcl-2(h):PS1(h) (binding) | bad(h) + Bcl-2(h) <==> bad(h):Bcl-2(h) (binding) | Bcl-2(h) + Bid(m) <==> Bcl-2(h):Bid(m) (binding) | BimEL(h) + Bcl-2(h) <==> BimEL(h):Bcl-2(h) (binding) | BimS(h) + Bcl-2(h) <==> BimS(h):Bcl-2(h) (binding) | BimAD(h) + Bcl-2(h) <==> BimAD(h):Bcl-2(h) (binding) | Bcl-2(h) --Caspase-3(h)--> protein remnants (processing) | Bcl-2(h) + Bik(h) <==> Bcl-2(h):Bik(h) (binding) | Bcl-2(h) + PUMA(h) <==> Bcl-2(h):PUMA(h) (binding) | BimEL-p22(m) + Bcl-2(h) <==> BimEL-p22(m):Bcl-2(h) (binding) | Bcl-2(h) + ASPP2(h) <==> Bcl-2(h):ASPP2(h) (binding) | p53(h) + Bcl-2(h) <==> p53(h):Bcl-2(h) (binding) | Bcl-2(h) + SMN(h) <==> Bcl-2(h):SMN(h) (binding) | Beclin-1(h) + Bcl-2(h) <==> Beclin-1(h):Bcl-2(h) (binding) | Bcl-2(h) + ATP --> Bcl-2(h){pS} + ADP (phosphorylation) | Bcl-2(h) + ATP --PKCalpha(h)--> Bcl-2(h){pS70} + ADP (phosphorylation) | Bcl-2(h) + ATP --ERK1(h)--> Bcl-2(h){pS70} + ADP (phosphorylation) | Bcl-2(h) + ATP --ERK2(h)--> Bcl-2(h){pS70} + ADP (phosphorylation) | Raf-1(h) + Bcl-2(h) <==> Raf-1(h):Bcl-2(h) (binding) | Bcl-2(h) + bad(m.s.) <==> Bcl-2(h):bad(m.s.) (binding) | Bcl-2(h) + ATP --> Bcl-2(h){p} + ADP (phosphorylation) | Bcl-2(h) --Caspase(h)--> Bcl-2-p23(h) + protein remnants (cleavage) | Bcl-2(h) --Caspase(h)--> protein remnants (cleavage) | Bcl-2(h) --Caspase(ha)--> protein remnants (cleavage) | Bcl-2(h) --Caspase-3(ha)--> protein remnants (cleavage) | Bcl-2(h) --Caspase-8(ha)--> protein remnants (cleavage) | PS2(m.s.) + Bcl-2(h) <==> PS2(m.s.):Bcl-2(h) (binding) | Bcl-2(h) --Caspase-8(h)--> protein remnants (cleavage) | Bcl-2(h) + NAC(h) <==> Bcl-2(h):NAC(h) (binding) | tBid(h) + Bcl-2(h) <==> tBid(h):Bcl-2(h) (binding) | Bcl-2(h) --> ICAD(h) (decrease of cleavage) | Cu-ZnSOD(h) + Bcl-2(h) <==> Cu-ZnSOD(h):Bcl-2(h) (binding) | Cu-ZnSOD(h) + Bcl-2(h) <==> Cu-ZnSOD(h):Bcl-2(h) (binding) | Bcl-2(h) + Beclin-1(h) <==> Bcl-2(h):Beclin-1(h) (binding) | Bcl-2(h) --> bad(m){pS136}{pS155} (decrease of phosphorylation) | Bcl-2(h) + bad(m) <==> Bcl-2(h):bad(m) (binding) | BCL2(h) --> Bcl-2(h) (expression). | Bcl-2(h){pS70} --> Bcl-2(h) + p (dephosphorylation) | BDNF(m.s.) --> Bcl-2(h) (increase of abundance) | Cdk5(h) --> Bcl-2(h) (increase of abundance) | AKT-2(m.s.) --> Bcl-2(h) (increase of abundance) | EGF(m.s.) --/ Bcl-2(h) (decrease of abundance) | s100a11(h) --> Bcl-2(h) (increase of abundance) | slc5a3(h) --/ Bcl-2(h) (decrease of abundance) | CHIP(h) --/ Bcl-2(h) (decrease of abundance) | Fam(h) --/ Bcl-2(h) (decrease of abundance) | TIP30(m.s.) --/ Bcl-2(h) (decrease of abundance) | IFNalpha2a(h) --> Bcl-2(h) (increase of abundance) | IFNbeta(m.s.) --> Bcl-2(h) (increase of abundance) | IFNgamma(h) --> Bcl-2(h) (increase of abundance) | opiomelanocortin(m.s.) --> Bcl-2(h) (increase of abundance) | UV --/ Bcl-2(h) (decrease of abundance) | ET-1(m.s.) --> Bcl-2(h) (increase of abundance) | Bcl-2-alpha(h) + IP3R1(m) <==> Bcl-2-alpha(h):IP3R1(m) (binding) | Bcl-2-alpha(h) + IP3R2(m) <==> Bcl-2-alpha(h):IP3R2(m) (binding) | Bcl-2-alpha(h) + IP3R3(m) <==> Bcl-2-alpha(h):IP3R3(m) (binding) | Bcl-2-alpha(h) + IP3R(m) <==> Bcl-2-alpha(h):IP3R(m) (binding) | Bcl-2-alpha(h) + Beclin-1(m) <==> Bcl-2-alpha(h):Beclin-1(m) (binding) | BCL2(h) --> Bcl-2-alpha(h) (expression). | BCL2(h) --> Bcl-2-beta(h) (expression). | BCL2(h) --> BCL2(h) (expression). | hsa-miR-15a --/ BCL2(h) (predicted) | hsa-miR-16 --/ BCL2(h) (predicted) | hsa-miR-15b --/ BCL2(h) (translational repression). |
|---|
Post Transcriptional Modification [Top] | |||
Location (AA) | PTM type | Literature | Database | 70 | Phosphoserine (by PKC) (By similarity). | Swiss-Prot 53.0 | 74 | Phosphothreonine | 12039864 | Phospho.ELM 6.0 | 56 | Phosphothreonine | 12039864 | Phospho.ELM 6.0 |
|---|---|---|---|
Methylation Profile [Top] | ||
Chromosome | Location | Source |
|---|---|---|
chr18 |
Promoter: 59137093 - 59139093 | Agilent_014791 |
chr18 |
Promoter: 59137093 - 59139093 | GSE27584 |
chr18 |
Promoter: 59137093 - 59139093 | GSE27584 |
chr18 |
Promoter: 59137093 - 59139093 | PMID:16242928 |
chr18 |
Promoter: 59137093 - 59139093 | PMID:16242928 |
chr18 |
Promoter: 59137093 - 59139093 | PMID:15569975 |
chr18 |
Promoter: 59137093 - 59139093 | PMID:15569975 |
chr18 |
Promoter: 59137093 - 59139093 | PMID:11724359 |
chr18 |
Promoter: 59137093 - 59139093 | PMID:11724359 |
chr18 |
Promoter: 59137093 - 59139093 | PMID:15172987 |
chr18 |
Promoter: 59137093 - 59139093 | PMID:15172987 |
chr18 |
Promoter: 59137093 - 59139093 | PMID:17139617 |
chr18 |
Promoter: 59137093 - 59139093 | PMID:17139617 |